Rap2 regulates androgen sensitivity in human prostate cancer cells

Prostate

Volumn 67, Issue 14, 2007, Pages 1590-1599

  Bigler, Dora ^a   Gioeli, Daniel ^b,d   Conaway, Mark R ^c   Weber, Michael J ^b,d   Theodorescu, Dan ^a,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c Public Health Sciences   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Androgen dependency; Prostate cancer; Prostate specific antigen (PSA); Rap2; Small GTPase

Indexed keywords

ANDROGEN; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; PROSTATE SPECIFIC ANTIGEN; PROTEIN DERIVATIVE; PROTEIN RAP2; RAP1 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ADENOCARCINOMA; ANDROGENS; ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP PHOSPHOHYDROLASES; HUMANS; MALE; MICE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RAP GTP-BINDING PROTEINS; RNA, NEOPLASM; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TELOMERE-BINDING PROTEINS;

EID: 35148863940     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20644     Document Type: Article

References (28)

1. Perez CA, Flair WR, Ihde DC, Labrie F. Cancer of the prostate. In: Vincent T DeVita, Samuel Hellman, Steven A Rosenberg, editors. Cancer: Principles and Practice of Oncology, 7th edition. Philadelphia: J.B. Lippincott Company; 1985. 929-964 p.
2. Gioeli D. Signal transduction in prostate cancer progression. Clin Sci 2005;108(4):293-308.
3. Gioeli D, Mandell JW, Petroni GR, Frierson HF Jr, Weber MJ. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 1999;59(2):27'9-284.
4. Gioeli D, Zecevic M, Weber MJ. Immunostaining for activated extracellular signal-regulated kinases in cells and tissues. Methods Enzymol 2001;332:343-353.
5. Voeller HJ, Wilding G, Gelmann EP. v-rasH expression confers hormone-independent in vitro growth to LNCaP prostate carcinoma cells. Mol Endocrinol 1991;5(2):209-216.
6. Bakin RE, Gioeli D, Sikes RA, Bissonette EA, Weber MJ. Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells. Cancer Res 2003;63(8):1981-1989.
7. Ehrhardt A, Ehrhardt GR, Guo X, Schrader JW. Ras and relatives-Job sharing and networking keep an old family together. Exp Hematol 2002;30(10):1089-1106.
8. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M. A rasrelated gene with transformation suppressor activity. Cell 1989;56:77-84.
9. Stork PJ. Does, Rap1 deserve a bad Rap? Trends Biochem Sci 2003;28(5):267-275.
10. Stork PJ. ERK signaling: Duration, duration, duration. Cell Cycle 2002;1(5):315-317.
11. Chen T, Cho RW, Stork PJ, Weber MJ. Elevation of cyclic adenosine 3′,5′-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells. Cancer Res 1999;59(1):213-218.
12. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW. LNCaP progression model of human prostate cancer: Androgen- independence and osseous metastasis. Prostate 2000;44(2):91-103.
13. Cleutjens KB, van Eekelen CC, van der Korput HA, Brinkmann AO, Trapman J. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem 1996;271(11):6379-6388.
14. Zecevic M, Catling AD, Eblen ST, Renzi L, Hittle JC, Yen TJ, Gorbsky GJ, Weber MJ. Active MAP kinase in mitosis: Localization at kinetochores and association with the motor protein CENP-E. J Cell Biol 1998;142(6):1547-1558.
15. Bakin RE, Gioeli D, Bissonette EA, Weber MJ. Attenuation of Ras signaling restores androgen sensitivity to hormone-refractory C 4-2prostate cancer cells. Cancer Res 2003;63(8):1975-1980.
16. Edwards J, Bartlett JMS. The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways. BJU Int 2005;95(9):1327-1335.
17. Rochette-Egly C. Nuclear receptors: Integration of multiple signalling pathways through phosphorylation. Cell Signal 2003; 15(4):355-366.
18. Obara Y, Labudda K, Dillon TJ, Stork PJ. PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci 2004;117(Pt 25):6085-6094.
19. Schmitt JM, Stork PJ. PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rapl. Mol Cell 2002;9(1): 85-94.
20. Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Prostate 2003;54(4):249-257.
21. Ohba Y, Mochizuki N, Matsuo K, Yamashita S, Nakaya M, Hashimoto Y, Hamaguchi M, Kurata T, Nagashima K, Matsuda M. Rap2 as a slowly responding molecular switch in the Rapl signaling cascade. Mol Cell Biol 2000;20(16):6074-6083.
22. Zwartkruis FJ, Wolthuis RM, Nabben NM, Franke B, Bos JL. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. EMBO J 1998;17(20):5905-5912.
23. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM. A family of cAMP-binding proteins that directly activate Rapl. Science 1998; 282(5397):2275-2279.
24. Cook SJ, Rubinfeld B, Albert I, McCormick F. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J 1993;12(9):3475-3485.
25. Buensuceso CS, O'Toole TE. The association of CRKII with C3G can be regulated by integrins and defines a novel means to regulate the mitogen-activated protein kinases. J Biol Chem 2000;275(17):13118-13125.
26. Hattori M, Minato N. Rap1 GTPase: Functions, regulation, and malignancy. J Biochem 2003;134(4):479-484.
27. Zhang Z, Mitra RS, Henson BS, Datta NS, McCauley LK, Kumar P, Lee JS, Carey TE, D'Silva NJ. Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma. Am J Pathol 2006;168(2)585-596.
28. Ohba Y. Regulation of a small GTPase Rap2. Hokkaido Igaku Zasshi 2001;76(1):13-20.